Significant Customers (Details Narrative) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2015 |
Sep. 30, 2015 |
Jun. 30, 2015 |
Mar. 31, 2015 |
Dec. 31, 2014 |
Sep. 30, 2014 |
Jun. 30, 2014 |
Mar. 31, 2014 |
Dec. 31, 2015 |
Dec. 31, 2014 |
Dec. 31, 2013 |
Dec. 31, 2012 |
|
Significant Customers [Line Items] | ||||||||||||
Revenue, Net | $ 8,163 | $ 4,390 | $ 2,191 | $ 5,860 | $ 8,972 | $ 5,130 | $ 1,797 | $ 6,171 | $ 20,604 | $ 22,070 | $ 25,032 | |
Sales [Member] | Walgreens [Member] | ||||||||||||
Significant Customers [Line Items] | ||||||||||||
Concentration Risk, Percentage | 15.80% | 18.90% | 20.40% | |||||||||
Sales [Member] | Wal Mart [Member] | ||||||||||||
Significant Customers [Line Items] | ||||||||||||
Concentration Risk, Percentage | 11.30% | 16.90% | 14.30% | |||||||||
Sales [Member] | CVS Health Corporation [Member] | ||||||||||||
Significant Customers [Line Items] | ||||||||||||
Concentration Risk, Percentage | 11.30% | 11.60% | ||||||||||
Accounts Receivable [Member] | ||||||||||||
Significant Customers [Line Items] | ||||||||||||
Concentration Risk, Percentage | 60.00% | 67.00% |
X | ||||||||||
- Definition Significant Customers Line Items. No definition available.
|
X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|